Previous studies have found that PRDM5 expression is lower in multiple cancer species than in adjacent tissues, including breast, ovarian, liver, lung, colon cancers, and cervical cancers [10], and that silencing or downregulation of PRDM5 is often caused by DNA methylation [10, 12, 14, 17]. Here, PRDM5 is linked to cervical carcinoma.